1)満田年宏(監訳):APICエリミネーションガイド 医療環境におけるクロストリジウム・ディフィシル(Clostridium difficile)伝播阻止のためのガイド,APIC,Washington, D.C.,2008
2)Murray PR, Baron EJ, Jorgensen JH, et al:Manual of Clinical Microbiology, 8th Edition, American Society for Microbiology Press, Washington, D.C., pp835-856, 2010
3)Cohen SH, Gerding DN, Johnson S, et al:Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31:431-435,2010
4)Oka K, Osaki T, Hanawa T, et al:Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases. J Clin Microbiol 50:915-921,2012
5)澤辺悦子,北村優佳,古畑紀子,他:Clostridium difficile感染症の迅速診断における糞便中C. difficile抗原およびトキシンA/B同時検出キット C. DIFF QUIK CHEK COMPLETEの有用性に関する検討.日本臨床微生物学雑誌 21:253-259,2011
6)Ticehurst JR, Aird DZ, Dam LM, et al:Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 44:1145-1149,2006
7)Tenover FC, Baron EJ, Peterson LR, et al:Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty? J Mol Diagn 13:573-582,2011
8)Su WY, Mercer J, Van Hal SJ, et al:Clostridium difficile testing: have we got it right? J Clin Microbiol 51:377-378,2013